Daiichi Sankyo, Inc.
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solut...
Daiichi Sankyo, Inc.'s Basic Information
Industry
Pharmaceutical Manufacturing
Headquarters
Basking Ridge, New Jersey, United States
Website
Founded Year
1866
Headcount
Over 10,000
Specialties
Innovation is integral to everything we do.Our medicines for cardiovascular, oncology and metabolic diseases are having a profound impact on countless lives today.Daiichi Sankyo, Inc. currently markets therapies in hypertension, thrombotic disorders, stroke risk reduction, dyslipidemia, diabetes, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. In addition, our research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases. PP-US-NP-0246 08/17Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo Group and is focused on the development of oncology therapies and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast and gastric cancer, tenosynovial giant cell tumor, metastatic melanoma, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy. PP-US-NP-1500 6/21OncologySpecialty MedicineDaiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines.
Daiichi Sankyo, Inc.'s Competitors
Medicon Valley Alliance
Denmark
RUNE INTELIGENCIA FARMACEUTICA
Viridae Clinical Sciences
Cincinnati, Ohio, United States
Hyundai Pharm
Seoul, South Korea
Homeostasis Laboratories, Inc.
United States
Employee Insights
Employee Function
Employee Location
Daiichi Sankyo, Inc.'s Top Employees
John Alexander
Chairman OF THE Board
Glenn Gormley
Head of R&D, Executive Chairman and President
Shreya Patel
Advisory board member, Anticoagulation
Amy Todd Klug
Executive Associate General Counsel, Litigation, Corporate Functions & Legal Operations
Punam Kumar
Senior Finance Associate
Find Your Next Customer with Better Data
Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.
⭐Top-ranked on G2 Crowd
🛡️GDPR compliant•Cancel anytime
✨Free credits every month!
Frequently Asked Questions Regarding Daiichi Sankyo, Inc.
Where is Daiichi Sankyo, Inc.'s headquarter located?
Daiichi Sankyo, Inc.'s headquarter are located at United States.
How many employees does Daiichi Sankyo, Inc. have?
Daiichi Sankyo, Inc. has Over 10,000 employees.
What is Daiichi Sankyo, Inc.'s official website?
Daiichi Sankyo, Inc.'s official website is https://daiichisankyo.us/
What industry does Daiichi Sankyo, Inc. belong to?
Daiichi Sankyo, Inc. is in the industry of Pharmaceutical Manufacturing
What does Daiichi Sankyo, Inc. do?
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solut...
What specialty does Daiichi Sankyo, Inc. have?
Innovation is integral to everything we do.Our medicines for cardiovascular, oncology and metabolic diseases are having a profound impact on countless lives today.Daiichi Sankyo, Inc. currently markets therapies in hypertension, thrombotic disorders, stroke risk reduction, dyslipidemia, diabetes, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. In addition, our research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases. PP-US-NP-0246 08/17Daiichi Sankyo, Inc. is a member of the Daiichi Sankyo Group and is focused on the development of oncology therapies and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast and gastric cancer, tenosynovial giant cell tumor, metastatic melanoma, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy. PP-US-NP-1500 6/21OncologySpecialty MedicineDaiichi Sankyo, Inc. is a member of the Daiichi Sankyo group of companies and is focused on the development of oncology therapies and specialty medicines.
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
